Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice

Molly Foote1, Haifa Qiao1, Kourtney Graham1

  • 1Department of Biomedical Sciences, Florida State University, College of Medicine, Tallahassee, Florida.

Biological Psychiatry
|April 13, 2015
PubMed
Abstract

Insights

14-3-3 protein dysfunction in mice leads to behavioral deficits mimicking schizophrenia symptoms. This involves synaptic changes in the brain, offering new insights into the disorder.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • The 14-3-3 protein family regulates critical neuronal functions.
  • Previous research links 14-3-3 dysregulation to schizophrenia in humans and animals.

Purpose of the Study:

  • To investigate behavioral and functional changes in mice with inhibited 14-3-3 protein activity.
  • To explore the link between 14-3-3 dysfunction and schizophrenia-like behaviors.

Main Methods:

  • Utilized transgenic mice expressing an isoform-independent 14-3-3 inhibitor peptide in the brain.
  • Characterized behavioral and functional alterations in these genetically modified mice.

Main Results:

  • 14-3-3 functional knockout (FKO) mice exhibited impairments in associative learning and memory.
  • These mice displayed behavioral deficits mirroring core schizophrenia symptoms.
  • Reduced dendritic complexity and spine density in forebrain excitatory neurons were observed, linked to altered synaptic connectivity.
  • Molecular analysis revealed dysregulated actin dynamics due to disrupted 14-3-3 regulation of phosphorylated cofilin.

Conclusions:

  • Established a connection between 14-3-3 protein dysfunction and schizophrenia-associated behavioral deficits.
  • Highlighted the role of synaptic alterations, specifically dendritic spine defects, in these deficits.
  • Provided molecular insights into the mechanisms underlying these changes, involving actin dynamics.